Clinical Research

Clinical Research

At the Irwin Retina Center

The Irwin Retina Center participates in a number of research grants and clinical trials sponsored by the National Institutes of Health and the National Eye Institute. There are also numerous FDA studies on new drugs and treatments for retinal diseases, including macular degeneration, diabetic retinopathy, diabetic macular edema and central vein occlusion. Patients or families interested in participating in clinical research can read about Ingalls current clinical trials online or call 708.596.8710 for more information.

What’s more, the Irwin Retina Center is internationally known for its contributions to education and research. Many of our retinal specialists hold academic positions at Rush University Medical Center in Chicago, and train residents and fellows.

They also:

  • Teach courses and symposia at medical institutions and meetings around the world
  • Have written many books and articles
  • Have invented new instruments in the field of vitreous and retina surgery
  • Have been recognized as some of the "Best Doctors in America" in retinal diseases
  • Have lobbied for the expansion of government reimbursement for medical services, and
  • Have served as president of both ophthalmic and specialty organizations and societies.

All Irwin Retina Center physicians are board certified in ophthalmology and fellowship trained at many of the finest programs in the country.

Equipped with the most advanced diagnostic and treatment procedures available anywhere, the center offers:

  • Digital imaging of the eye
  • Fluorescein and indocyanine green angiography to study normal and abnormal blood vessels in the back of the eye
  • Color fundus photography to diagnose retinal disease
  • B-scan ultrasonography, which helps identify abnormalities not visible with other instrumentation
  • Electroretinograph (ERG) and electro-oculogram (EOG) to measure the electrical response of the retina and study various inherited disorders
  • Ocular computerized tomography (OCT) to analyze the thickness of the retina and other abnormalities
  • Visual field testing to measure central and peripheral visual field defects
  • Retinal laser treatment to treat many retinal conditions
  • Intravitreal injections to treat retinal diseases such as macular degeneration, macular edema, diabetic retinopathy and retinal vein occlusion. Injections include the very latest therapies approved by the FDA, such as Lucentis, Avastin, Macugen and Eylea.

Our Physicians

Ingalls Resources

Success Stories

Irwin Retina Center: Landmark Macular Degenration Study Shows Two Drugs Equally Effective

Read More

National Study At Ingalls Compares Treatments for ‘Wet’ Macular Degeneration

Read More